Roht Laura, Laidre Piret, Tooming Mikk, Tõnisson Neeme, Nõukas Margit, Nurm Miriam, Roomere Hanno, Rekker Kadri, Toome Kadri, Fjodorova Olga, Murumets Ülle, Šamarina Ustina, Pajusalu Sander, Aaspõllu Anu, Salumäe Liis, Muhu Kristina, Soplepmann Jaan, Õunap Katrin, Kahre Tiina
Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, 50406 Tartu, Estonia.
Department of Clinical Genetics, Genetics and Personalized Medicine Clinic, Tartu University Hospital, 50406 Tartu, Estonia.
Cancers (Basel). 2023 Jul 18;15(14):3663. doi: 10.3390/cancers15143663.
Lynch syndrome (LS) is the most frequent genetically pre-disposed colorectal cancer (CRC) syndrome, accounting for 2-3% of all CRC cases. In Estonia, ~1000 new cases are diagnosed each year. This retroactive and prospective study aimed to estimate the prevalence of LS and describe disease-causing variants in mismatch repair (MMR) genes in a diagnostic setting and in the Estonian general population.
LS data for the diagnostic cohort were gathered from 2012 to 2022 and data for the general population were acquired from the Estonian Biobank (EstBB). Furthermore, we conducted a pilot study to estimate the improvement of LS diagnostic yield by raising the age limit to >50 years for immunohistochemistry analysis of MMR genes.
We estimated LS live birth prevalence between 1930 and 2003 in Estonia at 1:8638 (95% CI: 1: 9859-7588). During the study period, we gathered 181 LS individuals. We saw almost a six-fold increase in case prevalence, probably deriving from better health awareness, improved diagnostic possibilities and the implementation of MMR IHC testing in a broader age group.
The most common genes affected in the diagnostic and EstBB cohorts were and genes, respectively. The LS diagnosis mean age was 44.8 years for index cases and 36.8 years ( = 0.003) for family members. In the MMR IHC pilot study, 29% had LS.
林奇综合征(LS)是最常见的遗传性结直肠癌(CRC)综合征,占所有CRC病例的2%-3%。在爱沙尼亚,每年约有1000例新病例被诊断出来。这项回顾性和前瞻性研究旨在估计LS的患病率,并描述错配修复(MMR)基因在诊断环境和爱沙尼亚普通人群中的致病变异。
收集了2012年至2022年诊断队列的LS数据,并从爱沙尼亚生物银行(EstBB)获取了普通人群的数据。此外,我们进行了一项试点研究,以评估通过将MMR基因免疫组化分析的年龄限制提高到>50岁来提高LS诊断率的效果。
我们估计1930年至2003年期间爱沙尼亚LS的活产患病率为1:8638(95%CI:1:9859-7588)。在研究期间,我们收集了181例LS患者。病例患病率几乎增加了六倍,这可能源于健康意识的提高、诊断可能性的改善以及MMR免疫组化检测在更广泛年龄组中的应用。
诊断队列和EstBB队列中受影响最常见的基因分别是 和 基因。索引病例的LS诊断平均年龄为44.8岁,家庭成员为36.8岁(P = 0.003)。在MMR免疫组化试点研究中,29%的患者患有LS。